tradingkey.logo

BRIEF-Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

ReutersFeb 5, 2025 1:24 PM

-

  • QLARIS BIO ANNOUNCES POSITIVE TOPLINE DATA FROM TWO PHASE II TRIALS OF QLS-111 IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION

  • QLARIS BIO: QLS-111 MET ALL PRIMARY AND SECONDARY ENDPOINTS IN OSPREY AND APTERYX STUDIES

Source text: ID:nBw2Rf8z3a

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI